SteelPeak Wealth’s Amphastar Pharmaceuticals AMPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.26M Buy
48,708
+24
+0% +$519 0.03% 296
2026
Q2
$982K Buy
48,684
+222
+0.5% +$4.48K 0.03% 312
2026
Q1
$949K Sell
48,462
-7,233
-13% -$177K 0.03% 292
2025
Q4
$1.49M Hold
55,695
– – 0.05% 243
2025
Q3
$1.48M Sell
55,695
-100
-0.2% -$2.58K 0.05% 246
2025
Q2
$1.28M Hold
55,795
– – 0.05% 241
2025
Q1
$1.62M Buy
+55,795
New +$1.78M 0.07% 201

Other funds holding AMPH

SteelPeak Wealth's AMPH Position: Q3 2026 in Review

SteelPeak Wealth increased its Amphastar Pharmaceuticals (AMPH) stake by 0.05% in Q3 2026, buying an estimated $519 and bringing the position to 48,708 shares worth $1.26M. The position accounts for 0.03% of the portfolio, ranked #296.

SteelPeak Wealth first reported a position in AMPH in Q1 2025 and has held it in 7 quarters since. The position peaked at $1.62M in Q1 2025. 227 funds tracked by Wall St. Rank hold AMPH as of Q3 2026.

  • SteelPeak Wealth held 48,708 shares of Amphastar Pharmaceuticals worth $1.26M as of Q3 2026.
  • SteelPeak Wealth bought 24 Amphastar Pharmaceuticals shares in Q3 2026, an estimated $519.
  • Amphastar Pharmaceuticals made up 0.03% of SteelPeak Wealth's portfolio in Q3 2026, its #296 holding.
  • SteelPeak Wealth first reported a position in Amphastar Pharmaceuticals in Q1 2025 and has held it in 7 quarters since.
  • SteelPeak Wealth's Amphastar Pharmaceuticals position peaked at $1.62M in Q1 2025.
  • 227 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q3 2026.

Based on SteelPeak Wealth's 13F filing for Q3 2026, filed 16 Oct 2026.